🖼
FIGURE 3 — The extracellular matrix component perlecan/HSPG2 regulates radioresistance in p
active
paper figure
Created: 2026-04-21T18:29:40
By: paper_figures_tool
Quality:
50%
🔗 External
ID: paper-fig-paper-de0f65fde5fe-3
FIGURE 3Figure 3
The expression levels of HSPG2, LOXL2, LAMB3, and SRPX genes correlate with the clinical outcomes and cell radioresistance. (A) The Kaplan-Meier analyses of the association of HSPG2, LOXL2, LAMB3, and SRPX gene expression and biochemical recurrence-free survival (BRFS) in the TCGA PRAD PC gene expression dataset (N = 407). The stratification of patients into “high” and “low” groups according to gene expression was obtained using the online tool R2 Platform ( https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=kaplan_main ). The numbers on the x -axis represent time in years. Numbers at risk are added to the bottom of each graph. (B) RT-qPCR analysis of the relative HSPG2, LOXL2, SRPX, and LAMB3 mRNA expression in DU145 P and RR cells. N = 3; Error bars = SD; ** p < 0.01; *** p < 0.001. (C) Correlation of HSPG2, LOXL2, SRPX, and LAMB3 mRNA expression levels in normal tissues (MSKCC dataset, n = 29), primary tumors (MSKCC dataset, n = 131), and metastatic tumors (MSKCC dataset,
▸Metadata
| pmid | paper-de0f65fde5fe |
| caption | The expression levels of HSPG2, LOXL2, LAMB3, and SRPX genes correlate with the clinical outcomes and cell radioresistance. (A) The Kaplan-Meier analyses of the association of HSPG2, LOXL2, LAMB3, a |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC11325029/bin/fcell-12-1452463-g003.jpg |
| paper_title | The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells. |
| figure_label | FIGURE 3 |
| figure_number | 3 |
| _schema_version | 1 |
| source_strategy | pmc_api |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.